Last Updated : November 22, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
Iluvien
| Brand name | Generic name | Manufacturer | Indication(s) |
| Iluvien | fluocinolone acetate | Knight Therapeutics Inc. | Diabetic macular edema (DME) |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| SR0549-000 | 2017-11-22 | 2018-01-18 | Submit |
Probuphine
| Brand name | Generic name | Manufacturer | Indication(s) |
| Probuphine | buprenorphine hydrochloride | Knight Therapeutics Inc. | Opioid drug dependence, treatment |
| Project Number | Call for patient input | Patient input deadline | Submit patient input |
| SR0550-000 | 2017-11-22 | 2018-01-18 | Submit |
Last Updated : November 22, 2017